Who does the work in cancer control?

CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC

Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma

Novel immunotherapy approaches for small cell lung cancer

KEYNOTE-427 updates: First-line pembrolizumab monotherapy in patients with advanced clear cell renal cell carcinoma

Association of gene expression with clinical outcomes in RCC patients treated with pembrolizumab

Renal cell cancer: Highlights from ASCO 2020

FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advanced renal cell carcinoma

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

HERO: Relugolix versus leuprolide acetate for advanced prostate cancer

Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk